CHRONIC KIDNEY DISEASE AND HYPERTENSION
Clinical trials for CHRONIC KIDNEY DISEASE AND HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC KIDNEY DISEASE AND HYPERTENSION trials appear
Sign up with your email to follow new studies for CHRONIC KIDNEY DISEASE AND HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to shield failing kidneys
Disease control Recruiting nowThis study is testing if adding a new drug called baxdrostat to an existing kidney-protecting drug (dapagliflozin) works better than baxdrostat alone. The goal is to see if the combination can better reduce protein in the urine, a key sign of kidney damage, in adults with chronic…
Matched conditions: CHRONIC KIDNEY DISEASE AND HYPERTENSION
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
Major trial aims to halt kidney failure and heart deaths
Disease control Recruiting nowThis large, late-stage study is testing whether adding a new drug called baxdrostat to an existing kidney-protective medicine (dapagliflozin) works better than the existing medicine alone. It aims to see if the combination can more effectively slow kidney damage, prevent kidney f…
Matched conditions: CHRONIC KIDNEY DISEASE AND HYPERTENSION
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC